ProteoSign specifications


Unique identifier OMICS_18441
Name ProteoSign
Interface Web user interface
Restrictions to use None
Input data The input file(s) should be made out of merging multiple LC-MS/MS runs (fractionation, replication) of a single, possibly multiplexed, experiment and should not be the result of merging different or parallel experiments.
Input format TXT
Programming languages Javascript, PHP
Computer skills Basic
Version 1.0
Stability Stable
Maintained Yes


  • person_outline Ioannis Iliopoulos <>

Publication for ProteoSign

ProteoSign in publication

PMCID: 5875995
PMID: 29324674
DOI: 10.3390/metabo8010005

[…] that were differentially regulated on each side of the colon after calcitriol treatment. , we identified and quantified 6018 proteins at a 1% false discovery rate. volcano plots extracted from the proteosign platform from the triplicate uplc-ms/ms dataset plot the average change distribution between treated and untreated 2d cell culture. this data was plotted on a log2 scale on the x-axis […]

To access a full list of publications, you will need to upgrade to our premium service.

ProteoSign institution(s)
Medical School, Division of Basic Sciences, University of Crete, Heraklion, Greece; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK; Lawrence Berkeley National Labs, DOE Joint Genome Institute, Walnut Creek, CA, USA; Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA
ProteoSign funding source(s)
Supported by Wellcome Trust [WT094296MA and EU-FP7 ‘Sybilla’ number 201106]; EU-FP7 project InnovCrete.

ProteoSign reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ProteoSign